Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiapeng Xue
Institutions:
Hubei University of Medicine,
Taihe Hospital
Observed institutions:
Hubei University of Medicine,
Taihe Hospital
ORCID:
0009-0004-5767-4353
Observed ORCID:
0009-0004-5767-4353
OpenAlex ID:
A5020756084
Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer
2022
·
Zhi Li
, Hua Zhang
, et al.
·
Frontiers in Immunology
·
91
Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study
2022
·
Zhi Li
, Yun Shi
, et al.
·
Gland Surgery
·
15
TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
2023
·
Jiapeng Xue
, Hongfen Wu
, et al.
·
Discover Oncology
·
12
PDF
Selective targeting of the AKT1 (E17K) mutation: advances in precision oncology and therapeutic design
2025
·
Xiaoyan Chen
, Danfeng Zhang
, et al.
·
Discover Oncology
·
3
PDF
Lessons from the INSEMA trial: is sentinel lymph node biopsy in early-stage breast cancer stepping off the stage?
2025
·
Xiaoyan Chen
, Jiapeng Xue
, et al.
·
Frontiers in Oncology
·
2
PDF
Redefining “normal”: discovery of aneuploid epithelial cells in healthy breast tissue
2025
·
Xiaoyan Chen
, Xiaoling Liu
, et al.
·
Frontiers in Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
123
H-index:
3
I10-index:
3
Year
Topic
Type